InterAct Therapeutics, Inc.
New Form D on file · 2026-07-21 · the record
What the record says
Trailing twelve months. 810 filings in Other Health Care, totalled by week. The dot is this raise, $250K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Company officers on record
On the filing as: Executive Officer, Director.
Daniel Hargrove is named as Mr. Hargrove is the Ceo and a director of the Issuer. on the Form D that InterAct Therapeutics, Inc. filed with the SEC on 21 July 2026, one of 2 people that filing names.
On the filing as: Director.
Isaac Chan is named as Dr. Chan is a director of the Issuer on the Form D that InterAct Therapeutics, Inc. filed with the SEC on 21 July 2026, one of 2 people that filing names.
2 people named on the filing — 1 holding an executive role and 1 as a director only.
Named as of the 2026-07-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on InterAct Therapeutics, Inc.
- Source Check — verify Tyler Dove's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Tyler Dove for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist InterAct Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind InterAct Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.